Results Announcements News Details
Bliss GVS Pharma consolidated net profit rises 128.96% in the March 2026 quarter
(13-May-26 07:29)
Net profit of Bliss GVS Pharma rose 128.96% to Rs 35.58 crore in the quarter ended March 2026 as against Rs 15.54 crore during the previous quarter ended March 2025. Sales rose 29.80% to Rs 256.99 crore in the quarter ended March 2026 as against Rs 197.99 crore during the previous quarter ended March 2025.
For the full year,net profit rose 53.18% to Rs 129.13 crore in the year ended March 2026 as against Rs 84.30 crore during the previous year ended March 2025. Sales rose 14.50% to Rs 927.11 crore in the year ended March 2026 as against Rs 809.73 crore during the previous year ended March 2025.
| Particulars | Quarter Ended | Year Ended | ||||
| Mar. 2026 | Mar. 2025 | % Var. | Mar. 2026 | Mar. 2025 | % Var. | |
| Sales | 256.99 | 197.99 | 30 | 927.11 | 809.73 | 15 |
| OPM % | 17.29 | 10.65 | - | 17.69 | 15.65 | - |
| PBDT | 53.59 | 31.48 | 70 | 225.56 | 155.06 | 45 |
| PBT | 44.92 | 23.44 | 92 | 192.08 | 125.64 | 53 |
| NP | 35.58 | 15.54 | 129 | 129.13 | 84.30 | 53 |
Powered by Capital Market - Live News
